Red blood cell depletion from bone marrow and peripheral blood buffy coat: A comparison of two new and three established technologies

Transfusion

Volumn 55, Issue 6, 2015, Pages 1275-1282

  Sorg, Nadine ^a   Poppe, Carolin ^a   Bunos, Milica ^a   Wingenfeld, Eva ^a   Hümmer, Christiane ^a   Krämer, Ariane ^a   Stock, Belinda ^b   Seifried, Erhard ^a,b   Bonig, Halvard ^a,b,c  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD BUFFY COAT; BONE MARROW; CD34 SELECTION; CONTROLLED STUDY; DENSITY GRADIENT; DEPLETION; ENGRAFTMENT; ERYTHROCYTE; ERYTHROCYTE VOLUME; FEASIBILITY STUDY; HEMATOCRIT; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; MONONUCLEAR CELL; NORMAL HUMAN; POLYMORPHONUCLEAR CELL; TARGET CELL; THROMBOCYTE COUNT; TIME; APHERESIS; BLOOD CELL; BLOOD GROUP INCOMPATIBILITY; BONE MARROW CELL; CELL SEPARATION; COMPARATIVE STUDY; CYTOLOGY; DENSITY GRADIENT CENTRIFUGATION; DEVICES; ECONOMICS; EQUIPMENT DESIGN; EVALUATION STUDY; PROCEDURES;

FICOLL;

BLOOD BUFFY COAT; BLOOD CELLS; BLOOD COMPONENT REMOVAL; BLOOD GROUP INCOMPATIBILITY; BONE MARROW CELLS; CELL SEPARATION; CENTRIFUGATION, DENSITY GRADIENT; EQUIPMENT DESIGN; ERYTHROCYTE VOLUME; ERYTHROCYTES; FICOLL; HEMATOCRIT; HUMANS;

EID: 84930863923     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13001     Document Type: Article

References (29)

1. Blin N, Traineau R, Houssin S, et al. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source. Biol Blood Marrow Transplant 2010;16:1315-23.
2. Passweg JR, Baldomero H, Bregni M, et al. Hematopoietic SCT in Europe: data and trends in 2011. Bone Marrow Transplant 2013;48:1161-7.
3. Barrett AJ, Ringden O, Zhang MJ, et al. Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia. Blood 2000;95:3323-7.
4. Dominietto A, Lamparelli T, Raiola AM, et al. Transplant-related mortality and long-term graft function are significantly influenced by cell dose in patients undergoing allogeneic marrow transplantation. Blood 2002;100:3930-4.
5. Sierra J, Storer B, Hansen JA, et al. Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood 1997;89:4226-35.
6. Blacklock HA, Gilmore MJ, Prentice HG, et al. ABO-incompatible bone-marrow transplantation: removal of red blood cells from donor marrow avoiding recipient antibody depletion. Lancet 1982;2:1061-4.
7. Korístek Z, Mayer J. Bone marrow processing for transplantation using the COBE spectra cell separator. J Hematother Stem Cell Res 1999;8:443-8.
8. Witt V, Beiglböck E, Fritsch G. Bone marrow processing with the AMICUS separator system. J Clin Apher 2011;26:195-9.
9. Menichella G, Pierelli L, Dragani A, et al. A preliminary survey of Italian experience on bone marrow harvesting, processing and manipulation. The Italian Cooperative Study Group on Cell Manipulation in Hematology. Haematologica 1990;75:39-42.
10. Boyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 1968;97:77-89.
11. Daniel-Johnson J, Schwartz J. How do I approach ABO-incompatible hematopoietic progenitor cell transplantation? Transfusion 2011;51:1143-9.
12. Jin NR, Hill R, Segal G, et al. Preparation of red-blood-cell-depleted marrow for ABO-incompatible marrow transplantation by density-gradient separation using the IBM 2991 blood cell processor. Exp Hematol 1987;15:93-8.
13. Preti RA, Ahmed T, Ayello J, et al. Hemopoietic stem cell processing: comparison of progenitor cell recovery using the Cobe 2991 cell washer and the Haemonetics V50 apheresis system. Bone Marrow Transplant 1992;9:377-81.
14. Aktas M, Radke TF, Strauer BE, et al. Separation of adult bone marrow mononuclear cells using the automated closed separation system Sepax. Cytotherapy 2008;10:203-11.
15. Gee AP, Richman S, Durett A, et al. Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience. Cytotherapy 2010;12:684-91.
16. Brauninger S, Bialleck H, Thorausch K, et al. Mobilized allogeneic peripheral stem/progenitor cell apheresis with Spectra Optia v.5.0, a novel, automatic interface-controlled apheresis system: results from the first feasibility trial. Vox Sang 2011;101:237-46.
17. Brauninger S, Bialleck H, Thorausch K, et al. Allogeneic donor peripheral blood "stem cell" apheresis: prospective comparison of two apheresis systems. Transfusion 2012;52:1137-45.
18. Reinhardt P, Brauninger S, Bialleck H, et al. Automatic interface-controlled apheresis collection of stem/progenitor cells: results from an autologous donor validation trial of a novel stem cell apheresis device. Transfusion 2011;51:1321-30.
19. Schulz M, Bug G, Bialleck H, et al. Leucodepletion for hyper-leucocytosis - first report on a novel technology featuring electronic interphase management. Vox Sang 2013;105:47-53.
20. Schulz M, Bialleck H, Thorausch K, et al. Unstimulated leukapheresis in patients and donors: comparison of two apheresis systems. Transfusion 2014;54:1622-9.
21. Sörensen J, Jarisch A, Smorta C, et al. Pediatric apheresis with a novel apheresis device with electronic interface control. Transfusion 2013;53:761-5.
22. Steininger PA, Smith R, Geier C, et al. Leukapheresis in non-cytokine-stimulated donors with a new apheresis system: first-time collection results and evaluation of subsequent cryopreservation. Transfusion 2013;53:747-56.
23. Steininger PA, Strasser EF, Weiss D, et al. First comparative evaluation of a new leukapheresis technology in non-cytokine-stimulated donors. Vox Sang 2014;106:248-55.
24. Thorausch K, Schulz M, Bialleck H, et al. Granulocyte collections: comparison of two apheresis systems. Transfusion 2013;53:3262-8.
25. Apel M, Bruning M, Granzin M, et al. Integrated clinical scale manufacturing system for cellular products derived by magnetic cell separation, centrifugation and cell culture. Chemie Ingenieur Technik 2014;85:103-10.
26. Dauber K, Becker D, Odendahl M, et al. Enumeration of viable CD34(1) cells by flow cytometry in blood, bone marrow and cord blood: results of a study of the novel BD stem cell enumeration kit. Cytotherapy 2011;13:449-58.
27. Guttridge MG, Sidders C, Booth-Davey E, et al. Factors affecting volume reduction and red blood cell depletion of bone marrow on the COBE Spectra cell separator before haematopoietic stem cell transplantation. Bone Marrow Transplant 2006;38:175-81.
28. Larghero J, Rea D, Esperou H, et al. ABO-mismatched marrow processing for transplantation: results of 114 procedures and analysis of immediate adverse events and hematopoietic recovery. Transfusion 2006;46:398-402.
29. Scholl S, Klink A, Mugge LO, et al. Safety and impact of donor-type red blood cell transfusion before allogeneic peripheral blood progenitor cell transplantation with major ABO mismatch. Transfusion 2005;45:1676-83.